Browsing Tag
EURneffy
2 posts
Could pediatric anaphylaxis become the next growth opportunity for ALK Abelló’s EURneffy franchise?
Find out how EURneffy’s UK pediatric approval could strengthen ALK Abelló’s allergy strategy and challenge auto-injectors.
How EMA’s support for EURneffy 1 mg could disrupt Europe’s pediatric epinephrine market
EMA backs EURneffy 1 mg for pediatric anaphylaxis. Find out how ARS Pharmaceuticals and ALK-Abelló could reshape Europe’s allergy care landscape.